Posterior juxtascleral injection of anecortave acetate: Magnetic resonance and echographic imaging and localization in rabbit eyes

Retina

Volumn 27, Issue 2, 2007, Pages 247-252

  Jockovich, Maria Elena ^a   Murray, Timothy G ^a   Clifford, Paul D ^b   Moshfeghi, Andrew A ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Age related macular degeneration; Anecortave acetate; Angiostatic cortisene; Juxtascleral injection

Indexed keywords

ANECORTAVE; GADODIAMIDE;

ANATOMY; ANIMAL EXPERIMENT; ARTICLE; B SCAN; CANNULA; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; ECHOGRAPHY; EYE; EYEBALL FASCIA; FEMALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; RABBIT; SCLERA;

ANGIOGENESIS INHIBITORS; ANIMALS; CONNECTIVE TISSUE; DRUG DELIVERY SYSTEMS; FEMALE; INJECTIONS; MAGNETIC RESONANCE IMAGING; ORBIT; PREGNADIENEDIOLS; RABBITS; RETINA; SCLERA; TISSUE DISTRIBUTION; ULTRASONOGRAPHY;

EID: 33846993380     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.iae.0000242853.80913.63     Document Type: Article

References (16)

1. Penn JS, Rajaratnam VS, Collier RJ, Clark AF. The effect of an angiostatic steroid on neovascularization in a rat model of retinopathy of prematurity. Invest Ophthalmol Vis Sci 2001;42:283-290.
2. Ashino-Fuse H, Takano Y, Oikawa T, et al. Medroxyprogesterone acetate, an anti-cancer and anti-angiogenic steroid, inhibits the plasminogen activator in bovine endothelial cells. Int J Cancer 1989;44:859-864.
3. Blei F, Wilson EL, Mignatti P, Rifkin DB. Mechanism of action of angiostatic steroids: suppression of plasminogen activator activity via stimulation of plasminogen activator inhibitor synthesis. J Cell Physiol 1993;155:568-578.
4. Oikawa T, Hiragun A, Yoshida Y, et al. Angiogenic activity of rat mammary carcinomas induced by 7,12-dimethylbenz[a]anthracene and its inhibitions by medroxyprogesterone acetate: possible involvement of antiangiogenic action of medroxyprogesterone acetate in its tumor growth inhibition. Cancer Lett 1988;43:85-92.
5. McNatt LG, Li WW, Casey R, et al. Angiostatic steroids potentiated by sulfated cyclodextrins inhibit corneal neovascularization. Invest Ophthalmol Vis Sci 1991;32:2898-2905.
6. BenEzra D, Griffin BW, Maftzir G, et al. Topical formulations of novel angiostatic steroids inhibit rabbit corneal neovascularization. Invest Ophthalmol Vis Sci 1997;38:1954-1962.
7. Proia AD, Hirakata A, McInnes JS, et al. The effect of angiostatic steroids and b-cyclodextrin tetradecasulfate on corneal neovascularization in the rat. Exp Eye Res 1993;57:693-698.
8. Clark AF, Mellon J, Li XY, et al. Inhibition of intraocular tumor growth by topical application of the angiostatic steroid anecortave acetate. Invest Ophthalmol Vis Sci 1999;40:2158-2162.
9. Clark AF. AL-3789: a novel ophthalmic angiostatic steroid. Exp Opin Invest Drugs 1997;6:1867-1877.
10. Clark AF, McNatt L, Knepper PA. Angiostatic steroids as a new class of IOP lowering compounds. Invest Ophthalmol Vis Sci 1994;35:1483.
11. Augustin AJ, D'Amico DJ, Mieler WF, et al. Safety of posterior juxtascleral depot administration of the angiostatic cortisene anecortave acetate for treatment of subfoveal choroidal neovascularization in patients with age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 2005;243:9-12.
12. D'Amico DJ, Goldberg MF, Hudson H, et al. Anecortave Acetate Clinical Study Group. Anecortave acetate as monotherapy for the treatment of subfoveal lesions in patients with exudative age-related macular degeneration (AMD): interim (month 6) analysis of clinical safety and efficacy. Retina 2003;23:14-23.
13. D'Amico DJ, Goldberg MF, Hudson H, et al. Anecortave Acetate Clinical Study Group. Anecortave acetate as monotherapy for treatment of subfoveal neovascularization in age-related macular degeneration: twelve-month clinical outcomes. Ophthalmology 2003;110:2372-2383.
14. Albert DM, Tapper D, Robinson NL, Felman R. Retinoblastoma and angiogenesis activity. Retina 1984;4:189-194.
15. Tapper D, Langer R, Bellows AR, Folkman J. Angiogenesis capacity as a diagnostic marker for human eye tumors. Surgery 1979;86:36-40.
16. Walton DS, Grant WM. Retinoblastoma and iris neovascularization. Am J Ophthalmol 1968;65:598-599.